Literature DB >> 12542553

Hyperinsulinaemia as long-term predictor of death and ischaemic heart disease in nondiabetic men: The Malmö Preventive Project.

P Nilsson1, J-A Nilsson, B Hedblad, K-F Eriksson, G Berglund.   

Abstract

OBJECTIVES: Prospective studies have indicated that hyperinsulinaemia/insulin resistance is a risk factor for ischaemic heart disease (IHD), the risk decreasing with time of follow-up. Few studies have so far investigated the role of hyperinsulinaemia in the prediction of long-term total mortality.
SETTING: Section of Preventive Medicine, Department of Medicine, University Hospital, Malmö, Sweden.
SUBJECTS: A total of 6074 nondiabetic, middle-aged, healthy Swedish males. SCREENING EXAMINATION: We determined IHD risk factors including blood glucose and plasma insulin before and 2 h after an oral glucose tolerance test (OGTT). Total follow-up time was 19 years. Hyperinsulinaemia was defined as values above the 10th decentile of fasting or 2 h insulin concentration. MAIN OUTCOME MEASURES: Total mortality and cardiac event (CE) rate for IHD.
RESULTS: Unadjusted relative risks (RRs) for both death and CE were J-shaped with the highest relative risk (RR: 1.4-1.6) in the hyperinsulinaemic group compared with all other men. The RRs for death and CE were significant for fasting insulin but became nonsignificant after adjustment for other risk factors and also with a longer follow-up. The risk of death in hyperinsulinaemic men, defined on the basis of 2-h insulin level, increased with time of follow-up and was still significantly increased after 19 years [RR: 1.32 (95% CI: 1.05-1.65], even after adjustment for other risk factors.
CONCLUSIONS: Fasting hyperinsulinaemia was a predictor of total mortality and IHD in nondiabetic men, although not more significantly after adjustment for other risk factors and with lengthening of follow-up time. The 2-h postglucose hyperinsulinaemia appeared to be a stronger and independent predictor of mortality over long-term follow-up. These findings support the view that insulin resistance with associated cluster of risk factors predicts increased long-term risk of mortality and IHD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12542553     DOI: 10.1046/j.1365-2796.2003.01064.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  12 in total

1.  Demographic and cardiovascular risk factors modify association of fasting insulin with incident coronary heart disease and ischemic stroke (from the Atherosclerosis Risk In Communities Study).

Authors:  Laura J Rasmussen-Torvik; Hiroshi Yatsuya; Elizabeth Selvin; Alvaro Alonso; Aaron R Folsom
Journal:  Am J Cardiol       Date:  2010-05-15       Impact factor: 2.778

Review 2.  FFAs: do they play a role in vascular disease in the insulin resistance syndrome?

Authors:  Sudha S Shankar; Helmut O Steinberg
Journal:  Curr Diab Rep       Date:  2005-02       Impact factor: 4.810

3.  Dietary Insulinemic Potential and Risk of Total and Cause-Specific Mortality in the Nurses' Health Study and the Health Professionals Follow-up Study.

Authors:  Yi Wan; Fred K Tabung; Dong Hoon Lee; Teresa T Fung; Walter C Willett; Edward L Giovannucci
Journal:  Diabetes Care       Date:  2022-02-01       Impact factor: 19.112

4.  Triglyceride-Glucose Index is a Risk Marker of Incident COPD Events in Women.

Authors:  Suneela Zaigham; Hanan Tanash; Peter M Nilsson; Iram F Muhammad
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-06-17

5.  Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies.

Authors: 
Journal:  Diabetologia       Date:  2004-07-07       Impact factor: 10.122

6.  HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study.

Authors:  E L M Barr; A J Cameron; B Balkau; P Z Zimmet; T A Welborn; A M Tonkin; J E Shaw
Journal:  Diabetologia       Date:  2009-11-07       Impact factor: 10.122

Review 7.  Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes.

Authors:  Susanne Trost; Richard Pratley; Burton Sobel
Journal:  Curr Diab Rep       Date:  2006-02       Impact factor: 4.810

Review 8.  Fad Diets: Hype or Hope?

Authors:  Aravind R Kuchkuntla; Berkeley Limketkai; Sanjeev Nanda; Ryan T Hurt; Manpreet S Mundi
Journal:  Curr Nutr Rep       Date:  2018-12

9.  Low fasting plasma insulin is associated atrial fibrillation in men from a cohort study--the Malmö preventive project.

Authors:  Linda S B Johnson; Tord Juhlin; Gunnar Engström; Peter M Nilsson
Journal:  BMC Cardiovasc Disord       Date:  2014-08-24       Impact factor: 2.298

Review 10.  Metabolic syndrome: why the controversy?

Authors:  Richard E Pratley
Journal:  Curr Diab Rep       Date:  2007-02       Impact factor: 5.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.